Publications (27) JUAN MANUEL RAMIREZ SANCHEZ publications

2024

  1. Biotin-Based Strategies to Explore the World of Ubiquitin and Ubiquitin-Like Modifiers

    ChemBioChem, Vol. 25, Núm. 6

2023

  1. Linoleic acid improves PIEZO2 dysfunction in a mouse model of Angelman Syndrome

    Nature Communications, Vol. 14, Núm. 1

  2. P-Rex1 is a novel substrate of the E3 ubiquitin ligase Malin associated with Lafora disease

    Neurobiology of Disease, Vol. 177

2022

  1. HERC2 deficiency activates C-RAF/MKK3/p38 signalling pathway altering the cellular response to oxidative stress

    Cellular and Molecular Life Sciences, Vol. 79, Núm. 11

  2. Identification of substrates for human deubiquitinating enzymes (DUBs): An up-to-date review and a case study for neurodevelopmental disorders

    Seminars in Cell and Developmental Biology, Vol. 132, pp. 120-131

2021

  1. A proteomic approach for systematic mapping of substrates of human deubiquitinating enzymes

    International Journal of Molecular Sciences, Vol. 22, Núm. 9

  2. Konpartimentu-espezifikoko gertuko biotinilazioa: XPO1en esportazio-kargoak identifikatzeko hurbilketa berria

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 41, pp. 151-169

  3. The ubiquitin ligase Ariadne-1 regulates neurotransmitter release via ubiquitination of NSF

    Journal of Biological Chemistry, Vol. 296

2020

  1. How to Inactivate Human Ubiquitin E3 Ligases by Mutation

    Frontiers in Cell and Developmental Biology, Vol. 8

  2. Mass spectrometry-based characterization of Ub- and UbL-modified proteins

    Methods in Molecular Biology (Humana Press Inc.), pp. 265-276

2019

  1. Angelman sindromearen tratamendurako itu terapeutikoen bila: USP9X deubikuitinasa jomugan

    Osagaiz: osasun-zientzien aldizkaria, Vol. 3, Núm. 1, pp. 71-78

  2. Detailed dissection of UBe3A-mediated DDI1 ubiquitination

    Frontiers in Physiology, Vol. 10, Núm. MAY

  3. Impaired proteostasis in rare neurological diseases

    Seminars in Cell and Developmental Biology, Vol. 93, pp. 164-177

  4. UBE3Aren substratuak identifikatzen Angelman sindromearen ingurukoak argitzeko.

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 36, pp. 151-162

2018

  1. Neuronal proteomic analysis of the ubiquitinated substrates of the disease-linked E3 ligases parkin and Ube3a

    BioMed Research International, Vol. 2018

  2. Quantitative proteomics reveals neuronal ubiquitination of Rngo/Ddi1 and several proteasomal subunits by Ube3a, accounting for the complexity of Angelman syndrome

    Human Molecular Genetics, Vol. 27, Núm. 11, pp. 1955-1971

  3. Significant transcriptional changes in 15q duplication but not Angelman syndrome deletion stem cell-derived neurons

    Molecular Autism, Vol. 9, Núm. 1

2017

  1. A comprehensive platform for the analysis of ubiquitin-like protein modifications using in vivo biotinylation

    Scientific Reports, Vol. 7

  2. In vivo strategies to isolate and characterize the neuronal ubiquitinated proteome

    Neuromethods (Humana Press Inc.), pp. 179-189

  3. Quantitative proteomic analysis of Parkin substrates in Drosophila neurons

    Molecular Neurodegeneration, Vol. 12, Núm. 1